Not exact matches
Compared with a normal mouse cochlea (top),
cisplatin exposure reduces the number of outer hair cells (middle).
The addition of necitumumab to gemcitabine and
cisplatin chemotherapy improved overall survival and progression free survival by 21 % and 16 %, respectively, as
compared to chemotherapy alone in patients whose tumours expressed the EGFR protein.
The researchers then
compared tumor cells isolated from multiple different breast cancer patients and found that cells expressing lower amounts of Numb - 1 and -2 were more resistant to the chemotherapy agent
cisplatin.
indicate that there was high concentration of the
cisplatin within the tumor with the intratumoral method of administration when
compared with the two aerosol methods at the same time.
The only randomized study of adjuvant chemotherapy in mucosal melanoma demonstrated significantly increased relapse - free and overall survival in patients receiving temozolomide and
cisplatin, as
compared with interferon alfa - 2b or observation.